Pictet Asset Management Holding SA boosted its holdings in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) by 12.1% in ...

Schroder Investment Management Group trimmed its stake in shares of Lantheus Holdings ... and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent used in ...

Definity's President and Chief Executive Officer. 1 "Gross written premiums" is a supplementary financial measure composed of the total premiums for sale of insurance during a specified period ...

WATERLOO, ON, April 7, 2025 /CNW/ - Definity Financial Corporation ("Definity") (TSX: DFY) today announced that its 2024 Annual Report and its 2025 Management Information Circular are available at ...

Lantheus is promising up to $1.8 billion in milestone payments to POINT if the two radiotherapeutics get FDA approval and meet commercial objectives, plus royalties on net sales.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs).